Q2 2026 13F · SEC CIK 2056786
Lunate Capital Ltd
Asset managerFiled 2026-07-23 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $196.0M
- Reported positions
- 10
- Holdings vs S&P 500, 3 yrs
- —
- Average holding period
- 3 qtrs
Lunate Capital Ltd is an asset manager that reported 10 positions worth $196.0M in its Q2 2026 13F, filed 2026-07-23. Its largest holdings were Sailpoint Inc (SAIL, 22.4%), Birkenstock Holding PLC (BIRK, 22.2%), Lineage Inc (LINE, 13.2%).
Lunate Capital Ltd holdings all 10 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| SAILSailpoint Inc | 22.4% | +0.0% | $43.9M |
| BIRKBirkenstock Holding PLC | 22.2% | — | $43.5M |
| LINELineage Inc | 13.2% | +0.0% | $25.9M |
| BXSLBlackstone Secd Lending Fd | 12.1% | — | $23.7M |
| GSBDGoldman Sachs BDC Inc | 10.6% | — | $20.8M |
| MSDLMorgan Stanley Direct Lending Fund | 8.5% | — | $16.7M |
| OBDCBlue Owl Capital Corp. | 6.7% | — | $13.0M |
| NAVNNavan Inc | 2.3% | +0.0% | $4.6M |
| NMRANeumora Therapeutics Inc. | 1.8% | +0.0% | $3.6M |
| FIGFigma Inc | 0.1% | — | $240K |
What Lunate Capital Ltd bought and sold in Q2 2026, against Q1 2026.
New positions
- BIRK Birkenstock Holding PLC22.2% of 13F
- BXSL Blackstone Secd Lending Fd12.1% of 13F
- GSBD Goldman Sachs BDC Inc10.6% of 13F
- MSDL Morgan Stanley Direct Lending Fund8.5% of 13F
- OBDC Blue Owl Capital Corp.6.7% of 13F
- FIG Figma Inc0.1% of 13F
Added to
No position grew by more than 5%.
Reduced
No position shrank by more than 5%.
Sold out
- RVMD Revolution Medicines Incwas 44.4%
- RVMDW Revolution Medicines Incwas 0.7%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +169.7% /yr
- S&P 500 +20.1%
- 3 years
- —
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $196.0M | 10 |
| Q1 2026 | $120.4M | 6 |
| Q4 2025 | $264.3M | 6 |
| Q3 2025 | $220.7M | 6 |
| Q2 2025 | $178.1M | 6 |
Questions about Lunate Capital Ltd's portfolio
What stocks does Lunate Capital Ltd own?
Lunate Capital Ltd's latest 13F, for Q2 2026 and filed Jul 23, 2026, lists 10 positions worth $196.0M. The largest are Sailpoint Inc (SAIL) at 22.4%, Birkenstock Holding PLC (BIRK) at 22.2%, Lineage Inc (LINE) at 13.2%, Blackstone Secd Lending Fd (BXSL) at 12.1% and Goldman Sachs BDC Inc (GSBD) at 10.6%.
What did Lunate Capital Ltd buy last quarter?
In Q2 2026, Lunate Capital Ltd added a new position in Birkenstock Holding PLC (BIRK), a new position in Blackstone Secd Lending Fd (BXSL), a new position in Goldman Sachs BDC Inc (GSBD), a new position in Morgan Stanley Direct Lending Fund (MSDL) and a new position in Blue Owl Capital Corp. (OBDC), compared with its Q1 2026 filing.
What did Lunate Capital Ltd sell last quarter?
In Q2 2026, Lunate Capital Ltd sold all of Revolution Medicines Inc (RVMD) and sold all of Revolution Medicines Inc (RVMDW), compared with its Q1 2026 filing.
When is Lunate Capital Ltd's next 13F filing due?
13F filings are due 45 days after each quarter ends. Lunate Capital Ltd's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.